Literature DB >> 4212049

Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.

A S Levine, S C Schimpff, R G Graw, R C Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4212049

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  43 in total

1.  Blind therapy in emergencies.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Letter: Granulocyte transfusions.

Authors:  L Grossman
Journal:  Can Med Assoc J       Date:  1976-03-20       Impact factor: 8.262

3.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

4.  The use of plastic isolators to prevent infection in neutropenic patients.

Authors:  J M Goldman; A S Spiers; P C Trexler; H Gaya; A M Gordon
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

5.  Use of antibiotics. Infection in the compromised host.

Authors:  A P Gillett; R Wise; A M Geddes
Journal:  Br Med J       Date:  1978-07-29

Review 6.  Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.

Authors:  J W Hathorn; M Rubin; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.

Authors:  B Leng; B R Meyers; S Z Hirschman; G T Keusch
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

8.  Infection in immunodepressed patients. The approach to diagnosis and treatment.

Authors:  E H Nauta; R van Furth
Journal:  Infection       Date:  1975       Impact factor: 3.553

9.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

10.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.